» Authors » Maria Juliana Serrano-Nieto

Maria Juliana Serrano-Nieto

Explore the profile of Maria Juliana Serrano-Nieto including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 17
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mangas-Sanchez C, Garriga-Garcia M, Serrano-Nieto M, Garcia-Romero R, Alvarez Beltran M, Crehua-Gaudiza E, et al.
An Pediatr (Engl Ed) . 2023 Mar; 98(4):257-266. PMID: 36932016
Objectives: Based on the European and American Cystic Fibrosis (CF) consensus recommendations, an increase in vitamin D (VD) supplementation in patients with CF and insufficient or defficient levels was proposed....
2.
Mangas-Sanchez C, Garriga-Garcia M, Serrano-Nieto M, Garcia-Romero R, Alvarez-Beltran M, Crehua-Gaudiza E, et al.
Nutrients . 2021 Dec; 13(12). PMID: 34959965
Introduction: In recent years, guidelines for vitamin D supplementation have been updated and prophylactic recommended doses have been increased in patients with cystic fibrosis (CF). Objective: To evaluate safety and...
3.
Gallego-Gutierrez S, Navas-Lopez V, Kolorz M, Bartosova L, Lukac K, Luque-Perez S, et al.
J Crohns Colitis . 2015 May; 9(8):676-9. PMID: 25968582
Background: Azathioprine [AZA] and mercaptopurine [MP] are recommended for maintenance of steroid-free remission in children with Crohn`s disease [CD]. Azathioprine-induced pancreatitis, an idiosyncratic and major side effect, has been considered...
4.
Navas-Lopez V, Blasco-Alonso J, Giron-Fernandez-Crehuet F, Serrano-Nieto M, Sierra-Salinas C
Rev Esp Enferm Dig . 2014 Mar; 105(10):579-84. PMID: 24641454
Objectives: to describe the efficacy and safety of adalimumab (ADA) in inducing clinical remission and reducing inflammation of intestinal mucosa in children with Crohn´s disease (CD). Methods: we carried out...